Similar articles

• The incidence of malignant lymphoma and multiple myeloma in Hiroshima and Nagasaki atomic bomb survivors, 1945-1965.

  Nishiyama H, Anderson RE, Ishimaru T, Ishida K, Ii Y, Okabe N. Nishiyama H, et al. Cancer. 1973 Dec;32(6):1301-9. doi: 10.1002/1097-0142(197312)32:6<1301::aid-cncr2820320602>3.0.co;2-z. Cancer. 1973. PMID: 4757920 No abstract available.
• Monoclonal gammopathy of undetermined significance in atomic bomb survivors: incidence and transformation to multiple myeloma.

  Neriishi K, Nakashima E, Suzuki G. Neriishi K, et al. Br J Haematol. 2003 May;121(3):405-10. doi: 10.1046/j.1365-2141.2003.04287.x. Br J Haematol. 2003. PMID: 12716362
• Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

  Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Matsui T [corrected to Matsuo T], et al. Preston DL, et al. Radiat Res. 1994 Feb;137(2 Suppl):S68-97. Radiat Res. 1994. PMID: 8127953
• Mortality and cancer risk among the offspring (F1) of atomic bomb survivors.

  Yoshimoto Y, Mabuchi K. Yoshimoto Y, et al. J Radiat Res. 1991 Mar;32 Suppl:294-300. doi: 10.1269/jrr.32.supplement_294. J Radiat Res. 1991. PMID: 1762118 Review.
• Follow-up studies of breast cancer incidence among atomic bomb survivors.

  Tokunaga M, Land CE, Tokuoka S. Tokunaga M, et al. J Radiat Res. 1991 Mar;32 Suppl:201-11. doi: 10.1269/jrr.32.supplement_201. J Radiat Res. 1991. PMID: 1762108 Review. No abstract available.